LGND
|Ligand Pharmaceuticals Incorporated
NASDAQ
USD 102.19
+1.28|+1.27%
Current Price
USD 102.19
Change
+USD 1.28 (1.27%)
P/E Ratio
Dividend Yield
Market Cap
1.96B
Volume
164,245
Open
USD 100.29
Previous Close
USD 100.91
52-Week High
USD 129.90
52-Week Low
USD 77.43
About Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pn...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Todd C. Davis Ph.D.
Employees:68
Headquarters:Jupiter, USA
Website:www.ligand.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions